Catalog

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours

Author:

Krystle Maynard, DNP, RN

Desiree Reinken, PhD, APRN, NP-C

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist, Certified Registered Nurse Practitioner, Clinical Nurse Specialist, Licensed Practical Nurse, Licensed Vocational Nurse, Midwife, Registered Nurse, Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals: 

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-35

Course Description:

This course discusses the challenges of managing acute and chronic pain while maintaining safe prescribing practices. Content includes the risks of misuse, abuse, and addiction associated with controlled substances, and information on pain assessment.

Outcomes:

≥ 92% of participants will know how to incorporate both pharmacologic and non-pharmacologic therapies into a comprehensive, patient-centered plan for chronic pain.

Objectives:

After completing this continuing education course, the participant will be able to:

• Identify the risks of misuse, abuse, and addiction associated with controlled substances.
• Describe the key elements of a comprehensive pain assessment and methods to evaluate pain.
• Summarize evidence-based principles for the safe and effective use of controlled substances.
• Specify appropriate risk-mitigation strategies to promote patient safety.
• Compare pharmacologic and non-pharmacologic pain management modalities to support individualized, patient-centered care.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 (Meets Tennessee Requirements)

Contact Hour(s): 

2 Contact Hours, including 2 Pharmacology Hours

Author:

Krystle Maynard, DNP, RN, SANE-A

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

Course Description:

This course discusses the challenges of managing acute and chronic pain while maintaining safe prescribing practices. Content includes the risks of misuse, abuse, and addiction associated with controlled substances, information on pain assessment, and an overview of Tennessee regulations related to controlled-substance prescribing.

Outcomes:

≥ 92% of participants will know how to incorporate both pharmacologic and non-pharmacologic therapies into a comprehensive, patient-centered plan for chronic pain.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Identify the risks of misuse, abuse, and addiction associated with controlled substances.
2. Describe the key elements of a comprehensive pain assessment and methods to evaluate therapeutic outcomes.
3. Apply evidence-based principles and Tennessee regulatory requirements for the safe and effective prescribing of controlled substances.
4. Specify appropriate risk-mitigation strategies to promote patient safety.
5. Compare pharmacologic and non-pharmacologic pain management modalities to support individualized, patient-centered care.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

I

Contact Hour(s): 

1.5 Contact Hours, including 1.5 Advanced Pharmacology Hours

Author:

Julie Derringer, PhD, RN, CEN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353 

Course Description:

This course discusses the recognition and management of drug overdose, including new and emerging agents. Topics include traditional drugs of abuse as well as synthetic opioids, nitazenes, novel benzodiazepines, designer stimulants, and xylazine. Course content focuses on differentiating and defining major toxidromes, identifying appropriate antidotes, recognizing when to institute supportive care, and recognizing the limitations of toxicology screening. This course includes an overview of recent legislative and public health changes that have occurred, and uses a real-world case to emphasize critical clinical decision-making skills to improve patient care.

Outcomes:

≥ 92% of participants will know how to recognize key toxidromes and antidotes.

Objectives

After completing this continuing education course, the participant will be able to:

1. Improve their ability to identify traditional and emerging toxidromes.
2. Ensure the use of correct naloxone dosing protocols.
3. Integrate updated laws and policies into patient care plans and documentation.
4. Summarize targeted testing and clinical diagnosis supported by toxidrome recognition.
5. Identify evidence-based supportive care and symptom management.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This course meets Iowa requirements

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours

Author:

Julia Tortorice, RN, MBA, MSN, NEA-BC, CPHQ

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC) 

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses best practices for prescribing controlled substances, including the Centers for Disease Control and Prevention's (CDC) Clinical Practice Guidelines and recommendations.

Outcomes:

≥ 92% of participants will understand the Centers for Disease Control and Prevention's (CDC) 2022 Clinical Practice Guidelines for Opioids and Iowa laws regarding controlled substance prescribing and monitoring.

Objectives:

After completing this continuing education course, the participant will be able to:

After completing this continuing education course, the participant will be able to:

1. Explain the Centers for Disease Control and Prevention's (CDC's) guidelines for prescribing opiates.
2. Summarize the accepted best practices for assessing patients' risk for addiction and misuse of controlled substances.
3. Compare treatment for specific pain types.
4. Identify tools for identifying the risk of diversion, addiction, and misuse.
5. Describe the treatment of patients with acute, sub-acute, and chronic pain for whom nonpharmacological and noncontrolled pain medications have not been fully effective.
6. Identify three ways that controlled substances can be diverted.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.